Filter Results:
(67)
Show Results For
- All HBS Web (67)
- Faculty Publications (4)
Show Results For
- All HBS Web (67)
- Faculty Publications (4)
Page 1 of 67
Results →
- June 2020
- Article
Evaluation of Prescription Drug Monitoring Program Integration with Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates
By: A Jay Holmgren and Nate Apathy
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy solution to the opioid epidemic in the US. PDMPs offer prescribers a comprehensive view of patients’ controlled substance prescription history and can be used to monitor and reduce... View Details
Keywords: Prescription Drug Monitoring Programs; PDMPs; Electronic Health Records; Hospitals; Health Care and Treatment; Information Technology; Integration; Performance Evaluation
Holmgren, A Jay, and Nate Apathy. "Evaluation of Prescription Drug Monitoring Program Integration with Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates." JAMA Network Open 3, no. 6 (June 2020).
- August 2020
- Article
A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy
By: A Jay Holmgren, Alyssa Botelho and Allan M Brandt
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted... View Details
Keywords: Health Disorders; Information Technology; Programs; Technology Adoption; History; Government and Politics; Policy; United States
Holmgren, A Jay, Alyssa Botelho, and Allan M Brandt. "A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy." American Journal of Public Health 110, no. 8 (August 2020).
- 06 Sep 2022
- Research & Ideas
Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations
patient-assistance programs were likely to be profitable even if a small share of eligible patients used the manufacturer’s drugs as a result. This contributes to conditions that keep View Details
- Web
Drug & Alcohol Policy | About
alcohol. Additionally, the misuse of prescription drugs (sharing, buying, or using in a manner different than prescribed) is a violation of HBS policy. Although Massachusetts law now permits adults aged 21... View Details
- Web
2.3.1 Drug & Alcohol Policy | MBA
possessing or serving alcohol. HBS holds its students, faculty, and staff responsible for the consequences of their decisions to use or distribute illicit drugs or to serve or consume alcohol. Additionally, the misuse of View Details
- 09 Feb 2024
- HBS Case
Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive
what may at first blush appear to be an easier fix: new drugs such as Ozempic, Wegovy, and Mounjaro, says Harvard Business School Professor Regina E. Herzlinger, who has studied the American health care system for decades. Wegovy has been... View Details
- 01 Mar 2004
- News
Drug Imports a Hot Topic at Alumni Health-Care Conference
FDA Commissioner Mark B. McClellan doesn’t approve of Americans buying low-cost prescription drugs from Canada or over the Internet. But he understands what drives them to do so. At the HBS Health Industry... View Details
- 01 Mar 2007
- News
Daniel Vasella
fundamental problem. The Medicare prescription drug program that went into effect last year bars the federal government from negotiating with View Details
- 2021
- Working Paper
The Health Costs of Cost-Sharing
By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in... View Details
Chandra, Amitabh, Evan Flack, and Ziad Obermeyer. "The Health Costs of Cost-Sharing." NBER Working Paper Series, No. 28439, February 2021.
- 09 Oct 2020
- Blog Post
4 Things To Know About the MS/MBA Biotech
Since emigrating from Syria at the age of five, I have personally experienced the uphill battle of obtaining health care coverage as a non-US citizen. My family, along with many other immigrant and low-income families, are often forced to choose between receiving care... View Details
- 22 Feb 2016
- Research & Ideas
The ‘Mother of Fair Trade’ was an Unabashed Price Protectionist
“She also offered medical advice, delivery services, and prescription compounding—services not offered by department stores,” writes Sawyer. “Gleason also cultivated a reputation for providing indigent community members with medical... View Details
- 07 Dec 2010
- First Look
First Look: Dec. 7
the recent crisis the insured bonds have become significantly less liquid than uninsured municipal debt. Download the paper: http://www.hbs.edu/research/pdf/11-051.pdf The Learning Effects of Monitoring Authors:Dennis Campbell, Marc... View Details
Keywords: Sean Silverthorne
- 16 Jan 2018
- First Look
First Look at New Research and Ideas, January 16, 2018
on average, more valuable—they are more clinically effective; have higher patent citations; lead to more revenue and to higher stock market value. Using variation in the expansion of Medicare prescription View Details
Keywords: Sean Silverthorne
- 12 Jul 2016
- First Look
July 12, 2016
of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic (large-molecule) drugs represent a disproportionate and growing share of all drug spending in... View Details
Keywords: Sean Silverthorne
- 14 Nov 2017
- First Look
New Research and Ideas: November 14, 2017
October 2017 Negotiation Journal Prescriptions Based on a Realistic View of Human Behavior By: Bazerman, Max Abstract—No abstract available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53096 November–December 2017... View Details
Keywords: Carmen Nobel
- Web
Faculty & Advisors | MBA
M.D. MS/MBA Program Faculty Co-Chair for MS Professor of Stem Cell and Regenerative Biology at Harvard University, Chief of Pathways Consult Service at Massachusetts General Hospital Douglas Melton, Ph.D. MS/MBA View Details
- 15 Feb 2000
- Lessons from the Classroom
Delivering Information Services: A 30-Year Perspective
IPO in 1990 to a $10-billion company today, with a market value of close to $140 billion! I'm also doing research for a case on Drugstore.com, which is essentially a drug store "built" on the Internet. It's getting ready to... View Details
Keywords: by Staff
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare... View Details
Keywords: Sean Silverthorne
- 29 Oct 2013
- First Look
First Look: October 29
in a Chaotic World By: Wheeler, Michael Abstract—A member of the world-renowned Program on Negotiation at Harvard Law School introduces the powerful next-generation approach to negotiation. For many years, two approaches to negotiation... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
community and local entrepreneurs in India's software industry. We find that entrepreneurs located outside software hubs—in cities where monitoring and information flow on prospective clients is harder—rely significantly more on diaspora... View Details
Keywords: Martha Lagace